Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

NextGen Jane

NextGen Jane
2014 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$9M LATEST DEAL AMOUNT
15 INVESTORS
Description

Developer of a reproductive health platform intended to offer information on women's reproductive health. The company's platform uses a patented tampon collection technology to transform the diverse molecular signals from the endometrium, cervix, fallopian tubes and ovaries shed during menstruation into digital diagnoses for in-depth sequencing analysis and disease detection, enabling women to send their menstrual samples and predict reproductive diseases in a hassle free manner.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Laboratory Services (Healthcare)
Primary Office
  • 1090 63rd Street
  • Unit 4
  • Oakland, CA 94608
  • United States

+1 (925) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore NextGen Jane’s full profile, request a free trial.

NextGen Jane Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 01-Apr-2019 $9M 000.00 000.00 Completed Generating Revenue
2. Seed Round 09-Mar-2016 00.000 00.000 00.000 Completed Startup
1. Accelerator/Incubator 09-Dec-2015 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

NextGen Jane Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 0,000,000 00.000000 00.0 00.0 00 00.0 00.000
Seed 0,000,000 00.000000 00.00 00.00 00 00.00 00.00
To view this company’s complete Cap Table, request access »

NextGen Jane Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Veritas (genetics) Venture Capital-Backed Danvers, MA 000 000.00 0000000000 0 000.00
000000000 Formerly VC-backed New York, NY 00 00.000 000000&0 00.000
0000000 Venture Capital-Backed New York, NY 000 00000 00000000 00000
00000000 Venture Capital-Backed Vancouver, Canada 00 000.00 0000000000 0 000.00
00000000 Venture Capital-Backed New York, NY 000 000.00 0000000000 0 000.00
To view this company’s complete list of competitors, request access »

NextGen Jane Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Access Industries Corporation Minority 000 0000 000000 0
Angela Macfarlane Angel (individual) Minority 000 0000 000000 0
Anne Morriss Angel (individual) Minority 000 0000 000000 0
David Walt Angel (individual) Minority 000 0000 000000 0
Deborah Kilpatrick Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 15 investors. Get the full list »

NextGen Jane Executive Team (2)

Name Title Board
Seat
Contact
Info
Ridhi Tariyal Co-Founder & Chief Executive Officer
Stephen Gire Co-Founder, Chief Scientific Officer & Chief Product Designer